FREDERICK LANG to Genetic Therapy
This is a "connection" page, showing publications FREDERICK LANG has written about Genetic Therapy.
Connection Strength
0.705
-
Phosphorylation of Thr18 and Ser20 of p53 in Ad-p53-induced apoptosis. Neuro Oncol. 2008 Jun; 10(3):275-91.
Score: 0.185
-
Clinical trials of adenoviruses in brain tumors: a review of Ad-p53 and oncolytic adenoviruses. J Neurooncol. 2003 Dec; 65(3):237-46.
Score: 0.136
-
Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results. J Clin Oncol. 2003 Jul 01; 21(13):2508-18.
Score: 0.132
-
Apoptosis induced by adenovirus-mediated p53 gene transfer in human glioma correlates with site-specific phosphorylation. Cancer Res. 2002 Feb 15; 62(4):1069-76.
Score: 0.120
-
Preclinical Evaluation of Sequential Combination of Oncolytic Adenovirus Delta-24-RGD and Phosphatidylserine-Targeting Antibody in Pancreatic Ductal Adenocarcinoma. Mol Cancer Ther. 2017 04; 16(4):662-670.
Score: 0.085
-
Delta24-hyCD adenovirus suppresses glioma growth in vivo by combining oncolysis and chemosensitization. Cancer Gene Ther. 2005 Mar; 12(3):284-94.
Score: 0.037
-
Proteomic investigation of glioblastoma cell lines treated with wild-type p53 and cytotoxic chemotherapy demonstrates an association between galectin-1 and p53 expression. J Proteome Res. 2007 Feb; 6(2):869-75.
Score: 0.011